Z Du, J Sun,
Y Zhang, N Hesilaiti, Q Xia, H Cui, N Fan… - Biomolecules, 2023 - mdpi.com
Oncogenic mutations within the EGFR kinase domain are well-established driver mutations
in non–small cell lung cancer (NSCLC). Small-molecule tyrosine kinase inhibitors (TKIs) …